Added to YB: 2025-08-05
Pitch date: 2025-08-01
BAX [bullish]
Baxter International Inc.
+19.71%
current return
Author Info
DeepValue Capital is investing in quality turnaround companies. Sign up for the newsletter.
Company Info
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States.
Market Cap
$11.7B
Pitch Price
$21.64
Price Target
76.19 (+194%)
Dividend
0.18%
EV/EBITDA
9.50
P/E
-11.84
EV/Sales
1.71
Sector
Health Care Equipment and Supplies
Category
turnaround
Baxter | Smelling Blood in the Water at a $11B Giant
BAX: Post-75% decline, <8x FCF vs historical 24x. $13B revenue giant with strong margins in critical medical equipment (IV solutions, infusion pumps, smart beds). New CEO Hider (tripled ATS stock) targets 16.5% op margin by 2025. Risks: Novum IQ pump safety issues, recalls. PT $76.19 (250% upside) assuming 5% growth to $12.7B revenue by 2028.
Read full article (5 min)